Table 1.
AQP | Solute Selectivity | Localization | Disease Implications | Ref. |
---|---|---|---|---|
AQP0 | Water | Eye | Cataract | [24] |
AQP1 | Water | Brain, kidney, red blood cells | Tumor genesis and metastasis | [25] |
AQP2 | Water | Kidney | Nephrogenic diabetes | [26] |
AQP3 | Water, glycerol, urea | Liver, kidney, skin, intestine, eye, red blood cells | Skin cancer | [27] |
AQP4 | Water | Brain, intestine, kidney eye, nose, salivary duct, placenta, muscle | Brain edema, epilepsy, neuromyelitis optica | [28,29,30,31] |
AQP5 | Water | Lungs, salivary glands, sweat glands, eye, pancreas | Asthma, cystic fibrosis | [32,33] |
AQP6 | Water | Kidney | Unknown | [34] |
AQP7 | Water, glycerol, urea | Adipose tissue, liver, kidney, testis, heart muscle | Obesity, T2DM | [35,36,37] |
AQP8 | Water | Intestine | Ulcerative colitis | [38] |
AQP9 | Water, glycerol, urea | Liver, red blood cells | Obesity, T2DM. NAFLD | [37,39,40] |
AQP10 | Water, glycerol, urea | Small intestine | Unknown | [41] |
AQP11 | Water | Liver, testis, kidney | Polycystic kidney disease | [42] |
AQP12 | Unknown | Pancreas | Pancreatitis | [43] |
T2DM—type 2 diabetes mellitus; NAFLD—non-alcoholic fatty liver disease.